Composition for preventing, relieving or treating colitis, containing complex extracts
AssigneeUniversity-Industry Cooperation Group of Kyung Hee University
InventorsDong Hyun KIM, Myung Joo HAN
Life of this patent
Estimating the term…
Abstract
The present invention relates to a novel use of an Anemarrhena asphodeloides Bunge extract, and the like, and a Rhizoma Coptidis extract, and the like, and specifically, provides a composition for preventing, relieving, or treating colitis, including, as active ingredients: one or more selected from the Anemarrhena asphodeloides Bunge extract, a C3 to C8-alcohol-soluble fraction of the Anemarrhena asphodeloides Bunge extract, mangiferin, a pharmaceutically acceptable salt of mangiferin, neomangiferin, or a pharmaceutically acceptable salt of neomangiferin; and one or more selected from a Rhizoma Coptidis extract and a C3 to C8-alcohol-soluble fraction of the Rhizoma Coptidis extract.
Claims21
A pharmaceutical composition for preventing or treating colitis, comprising as active ingredients:
- one or more selected from an Anemarrhena asphodeloides Bunge extract, a C3 to C8-alcohol-soluble fraction of the Anemarrhena asphodeloides Bunge extract, mangiferin, a pharmaceutically acceptable salt of mangiferin, neomangiferin, and a pharmaceutically acceptable salt of neomangiferin;
- and
- one or more selected from a Rhizoma Coptidis extract and a C3 to C8-alcohol-soluble fraction of the Rhizoma Coptidis extract.
A food composition for preventing or improving colitis, comprising, as active ingredients:
- one or more selected from an Anemarrhena asphodeloides Bunge extract, a C3 to C8-alcohol-soluble fraction of the Anemarrhena asphodeloides Bunge extract, mangiferin, a sitologically acceptable salt of mangiferin, neomangiferin, and a sitologically acceptable salt of neomangiferin;
- and
- one or more selected from a Rhizoma Coptidis extract and a C3 to C8-alcohol-soluble fraction of the Rhizoma Coptidis extract.
Dependencies are inferred from the claim text.